Fundraising FoxCambridge Capital Group — Full Portfolio
13 tracked investments · listed companies and verified rows first
iFAST Diagnostics develops rapid antimicrobial susceptibility testing (AST) technology that delivers susceptibility test results in under 3 hours, significantly faster than the standard 40-hour process.
BiotechHealthtechMedical DevicesWhiteley, GB
Co-investorsMeridian Health VenturesInnovate UKRaw VenturesFuture Planet CapitalUK Innovation & Science Seed Fund
Semarion is a University of Cambridge spin-out developing the SemaCyte platform, which converts adherent cells into barcoded, ready-to-use reagents for accelerated drug discovery and cell-based research.
BiotechDeep TechMedical DevicesNew MaterialsSaaSCambridge, GB
Jeroen Verheyen(CEO and Co-Founder)inTarun Vemulkar(Co-founder & CTO)in
Co-investorsThe FSE GroupFound CapitalStart CodonEMV CapitalMartlet CapitalParkwalk Advisors
Solytics Partners provides risk management, financial crime and compliance (AML/CFT), data analytics, and ESG/climate risk services and technology to financial institutions such as banks, capital markets firms, and insurers.
AI & Machine LearningData & InfrastructureEnterprise SoftwareFintechSaaS
Co-investorsMartlet CapitalQED Investors
AreCor develops proprietary pharmaceutical products for diabetes, obesity, and cardiometabolic diseases using its Arestat technology platform.
BiotechDeep TechHealthtech
Sarah Howellin
Co-investorsAlbionVCCalculus Capital Ltd.Seneca Partners
Enval develops a microwave-induced pyrolysis technology that recycles low-density and complex plastic packaging waste, converting it into oil feedstock to produce new plastic.
Circular EconomyCleantechNew Materials
Co-investorsAnglia Capital GroupCambridge Angels groupGEIF VenturesUniversity of Cambridge Enterprise
Featurespace provides an AI-powered fraud detection platform deployed across financial institutions, payment processors, and insurance companies globally.
AI & Machine LearningCybersecurityFintech
Bill Fitzgerald(Founder)Dave Excell(Founder)
Co-investorsBright Pixel CapitalGray VenturesHighland EuropeInsight PartnersMissionOGTTV Capital
IQGeo builds AI-powered geospatial network management software that unifies the planning, design, construction, and operation of physical network infrastructure into a single platform.
AI & Machine LearningEnterprise SoftwareSaaS
PneumaCare develops Structured Light Plethysmography (SLP) technology and markets Thora-3Di, a non-contact, non-invasive 3D-imaging device for lung function assessment used in paediatric, ICU, and thoracic surgery hospital settings.
Digital HealthHealthtechMedical DevicesCambridge, GB
Bart A. Lewin(Chief Executive Officer)in
Co-investorsCambridge Angels group
Ubisense provides real-time location tracking and asset management solutions for manufacturing, logistics, and facility operations.
Advanced ManufacturingEnterprise SoftwareIoTLogistics & Supply ChainSaaSCambridge, GB
Dr Andy Ward(Chief Technology Officer)Selva Selvaratnam(Chief Executive Officer)Kate Edge(Chief Financial Officer)in
Co-investorsInvestcorp
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
10to8Cambridge CMOS SensorsOval Medical TechnologiesTouchtype Limited
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.